SCOPE FLUIDICS SA ZY-10 Asset Resilience Ratio
SCOPE FLUIDICS SA ZY-10 asset resilience ratio. SCOPE FLUIDICS SA ZY-10 (S84) has an Asset Resilience Ratio of 32.55% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can SCOPE FLUIDICS SA ZY-10 fund operations to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of SCOPE FLUIDICS SA ZY-10 (2023–2025)
Asset resilience ratio of SCOPE FLUIDICS SA ZY-10 from 2023 to 2025. This chart shows how SCOPE FLUIDICS SA ZY-10's Asset Resilience Ratio has changed over time. Read total liabilities of SCOPE FLUIDICS SA ZY-10 for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down SCOPE FLUIDICS SA ZY-10's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of SCOPE FLUIDICS SA ZY-10.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €63.77 Million | 32.55% |
| Total Liquid Assets | €63.77 Million | 32.55% |
Asset Resilience Insights
- Very High Liquidity: SCOPE FLUIDICS SA ZY-10 maintains exceptional liquid asset reserves at 32.55% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
SCOPE FLUIDICS SA ZY-10 Industry Peers by Asset Resilience Ratio
Compare SCOPE FLUIDICS SA ZY-10's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Zhejiang DiAn Diagnostics Co
SHE:300244 |
Diagnostics & Research | 3.61% |
|
Shanghai Runda Med Tech Co
SHG:603108 |
Diagnostics & Research | 0.42% |
|
Cowealth Medical China Co.Ltd.
SHG:603122 |
Diagnostics & Research | 2.25% |
|
Lumibird SA
PA:LBIRD |
Diagnostics & Research | 22.85% |
|
Monash Ivf Group Ltd
AU:MVF |
Diagnostics & Research | 1.60% |
|
Leveljump Healthcare Corp
V:JUMP |
Diagnostics & Research | 32.45% |
|
Avricore Health Inc
V:AVCR |
Diagnostics & Research | 1.71% |
|
Inoviq Ltd
AU:IIQ |
Diagnostics & Research | 56.29% |
SCOPE FLUIDICS SA ZY-10 Asset Resilience Ratio by Year (2023–2025)
SCOPE FLUIDICS SA ZY-10 asset resilience ratio by year from 2023 to 2025. The table below shows the annual Asset Resilience Ratio data for SCOPE FLUIDICS SA ZY-10.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 32.55% | €63.77 Million ≈ $74.56 Million |
€195.94 Million ≈ $229.07 Million |
+19.71pp |
| 2024-12-31 | 12.84% | €22.19 Million ≈ $25.94 Million |
€172.87 Million ≈ $202.10 Million |
-7.76pp |
| 2023-12-31 | 20.60% | €20.90 Million ≈ $24.44 Million |
€101.49 Million ≈ $118.65 Million |
-- |
About SCOPE FLUIDICS SA ZY-10
Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. The company offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is based in Warsaw, Poland.